KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Travere Therapeutics (TVTX) Long-Term Debt Issuances: 2013-2022

  • Travere Therapeutics' Long-Term Debt Issuances was N/A to $316.2 million in Q1 2022 from the same period last year, while for Mar 2022 it was $319.1 million, marking a year-over-year change of. This contributed to the annual value of $316.2 million for FY2022, which is N/A change from last year.
  • Travere Therapeutics' Long-Term Debt Issuances amounted to $316.2 million in Q1 2022, which was up 31,525.00% from $1.0 million recorded in Q3 2014.
  • Travere Therapeutics' Long-Term Debt Issuances' 5-year high stood at $316.2 million during Q1 2022, with a 5-year trough of $316.2 million in Q1 2022.
  • Over the past 1 years, Travere Therapeutics' median Long-Term Debt Issuances value was $316.2 million (recorded in 2022), while the average stood at $316.2 million.